Accelerated generation of human induced pluripotent stem cells from human oral mucosa using episomal plasmid vectors and maternal transcription factor Glis1
書誌事項
- タイトル
- Accelerated generation of human induced pluripotent stem cells from human oral mucosa using episomal plasmid vectors and maternal transcription factor Glis1
- タイトル別名
-
- エピソーマルプラスミドベクターと母性転写因子Glis1を用いたヒト口腔粘膜からのヒト人工多能性幹細胞樹立の加速化
- 著者
- 柏木, 隆宏
- 学位授与大学
- 大阪歯科大学
- 取得学位
- 博士(歯学)
- 学位授与番号
- 甲第776号
- 学位授与年月日
- 2016-03-11
説明
Objective: Induced pluripotent stem cells (iPSCs) possess high pluripotency and differentiation potential and may constitute a possible source of autologous stem cells for clinical applications. However, the lengthy reprogramming process (up to 1 month) remains one of the most significant challenges facing standard virus-mediated methodology. The transcription factor Gli-like transcription factor Glis1 is highly expressed in unfertilized eggs and one-cell-stage embryos. In this study, iPSCs were generated using a combination of primary human oral mucosa fibroblasts (HOFs) and episomal plasmid vectors expressing transcription factors including Glis1.Materials and Methods: HOFs were established from 3-mm in diameter oral mucosa tissue using the skin trephine of a 23-year-old Asian man. Human iPSCs were generated from the established HOFs using the following episomal plasmid vectors: pCXLE-hOCT3/4-shp53-F that expresses OCT3/4 and shRNA against p53; pCXLE-hSK that expresses SOX2 and KLF4; pCXLE-hUL that expresses L-MYC and LIN28; and pCXLE-hGlis1 that expresses Glis1.Results: Fifty colonies of human embryonic stem (ES)-like cells were observed as early as 20 days following initial episomal plasmid vector transduction. The resulting cell lines shared several characteristics with human ES cells, including morphology, pluripotency-associated gene and protein markers, karyotype analysis, and the ability to differentiate in vivo into all three germ layers.Conclusions: Our method, combining the use of HOFs and episomal plasmid vectors expressing OCT3/4, SOX2, KLF4, L-MYC, shRNA against p53, LIN28, and Glis1, offers a powerful tool for safely and rapidly generating bona fide human iPSCs and facilitates the application of iPSC technology to biomedical research.
2015
収集根拠 : 博士論文(自動収集)
資料形態 : テキストデータ
コレクション : 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文
Objective: Induced pluripotent stem cells (iPSCs) possess high pluripotency and differentiation potential and may constitute a possible source of autologous stem cells for clinical applications. However, the lengthy reprogramming process (up to 1 month) remains one of the most significant challenges facing standard virus-mediated methodology. The transcription factor Gli-like transcription factor Glis1 is highly expressed in unfertilized eggs and one-cell-stage embryos. In this study, iPSCs were generated using a combination of primary human oral mucosa fibroblasts (HOFs) and episomal plasmid vectors expressing transcription factors including Glis1.Materials and Methods: HOFs were established from 3-mm in diameter oral mucosa tissue using the skin trephine of a 23-year-old Asian man. Human iPSCs were generated from the established HOFs using the following episomal plasmid vectors: pCXLE-hOCT3/4-shp53-F that expresses OCT3/4 and shRNA against p53; pCXLE-hSK that expresses SOX2 and KLF4; pCXLE-hUL that expresses L-MYC and LIN28; and pCXLE-hGlis1 that expresses Glis1.Results: Fifty colonies of human embryonic stem (ES)-like cells were observed as early as 20 days following initial episomal plasmid vector transduction. The resulting cell lines shared several characteristics with human ES cells, including morphology, pluripotency-associated gene and protein markers, karyotype analysis, and the ability to differentiate in vivo into all three germ layers.Conclusions: Our method, combining the use of HOFs and episomal plasmid vectors expressing OCT3/4, SOX2, KLF4, L-MYC, shRNA against p53, LIN28, and Glis1, offers a powerful tool for safely and rapidly generating bona fide human iPSCs and facilitates the application of iPSC technology to biomedical research.
2015
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1910865335674697728
-
- NII論文ID
- 500001193421
- 500001668957
- 500001483266
-
- 本文言語コード
- en
-
- データソース種別
-
- IRDB
- NDLサーチ